Artiva Biotherapeutics, Inc. ARTV Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s accrued manufacturing costs?
- Artiva Biotherapeutics, Inc. (ARTV) reported accrued manufacturing costs of $3.18M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s accrued manufacturing costs changed year-over-year?
- Artiva Biotherapeutics, Inc.'s accrued manufacturing costs increased by 25.8% year-over-year, from $2.53M to $3.18M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s accrued manufacturing costs?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s accrued manufacturing costs has grown at a 36.8% compound annual growth rate (CAGR), from $4.05M to $7.57M.